Atıf Formatları
Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy
  • IEEE
  • ACM
  • APA
  • Chicago
  • MLA
  • Harvard
  • BibTeX

T. Z. Mustafayev Et Al. , "Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy," BMC CANCER , vol.24, no.1, 2024

Mustafayev, T. Z. Et Al. 2024. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy. BMC CANCER , vol.24, no.1 .

Mustafayev, T. Z., Turna, M., Bolukbasi, Y., Tezcanli, E. K., Guney, Y., DİNÇBAŞ, H. F., ... ATASOY, B. M.(2024). Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy. BMC CANCER , vol.24, no.1.

Mustafayev, Teuta Et Al. "Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy," BMC CANCER , vol.24, no.1, 2024

Mustafayev, Teuta Z. Et Al. "Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy." BMC CANCER , vol.24, no.1, 2024

Mustafayev, T. Z. Et Al. (2024) . "Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy." BMC CANCER , vol.24, no.1.

@article{article, author={Teuta Zoto Mustafayev Et Al. }, title={Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy}, journal={BMC CANCER}, year=2024}